美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Defiance Daily Target 2X Long MRNA ETF

81.41

+7.5710.25%

盤後：82.000.5900+0.72%19:51 EDT

成交量：25.97萬

成交額：2,154.65萬

市值：2,605.12萬

市盈率：- -

高：87.50

開：74.73

低：72.45

收：73.84

52周最高：143.84

52周最低：14.95

股本：32.00萬

流通股本：32.00萬

量比：1.11

換手率：81.17%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

莫德納疫苗管線逐漸清晰，新藥前景牽動市場

更正-在等待美國就流感疫苗作出關鍵決定之際，Moderna的季度營收超出預期

Moderna第二季度每股收益-1.97美元，優於IBES預期的-2.08美元

Moderna(MRNA.US)盤前跌5.7%二季度營收略低於預期。

Moderna宣佈：mRNA-1403 III期中期分析未達早期成功統計標準，正籌備新增隊列招募

Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點

今日關注要點——7月31日（星期五）

默克、惠康與一家全球衞生組織合作，共同研製埃博拉疫苗以用於臨床試驗

總部位於荷蘭阿姆斯特丹的全球生物製藥公司 ARGENX將以每股77美元的現金收購FORTE BIOSCIENCES。

數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法

安永：至2028年全球前25大醫藥企業存在千億美元增長缺口

生物技術專家希望美國食品藥品監督管理局（FDA）的藥物評審基於科學，而非政治

莫德納稱，CureVac因就新冠疫苗專利提起訴訟而違反了協議

Moderna宣佈首例患者接受針對實體瘤的研究性腫瘤靶向癌症抗原療法一期臨床試驗

賽諾菲就新冠疫苗技術起訴輝瑞和莫德納

免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市擬募資1億美元

免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市擬募資1億美元

免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市擬募資1億美元

傑富瑞：將Moderna(MRNA.US)目標價從53美元上調至60美元。

重温-美國股市：標普500指數接近紀錄高位，投資者目光轉向財報季

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/MRNX/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":81.41,"timestamp":1789156800000,"preClose":73.84,"halted":0,"volume":259735,"hourTrading":{"tag":"盘后","latestPrice":82,"preClose":81.41,"latestTime":"19:51 EDT","volume":2532,"amount":208418.93,"timestamp":1789170707443,"change":0.59,"changeRate":0.007247,"amplitude":0.017074},"delay":0,"changeRate":0.10251895991332602,"floatShares":320000,"shares":320000,"eps":0,"marketStatus":"休市中","change":7.57,"latestTime":"09-11 16:00:00 EDT","open":74.73,"high":87.5,"low":72.45,"amount":21546481.856725,"amplitude":0.203819,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":73.84,"sharesOutstanding":30000,"nav":73.79,"aum":23612800,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":74.76,"preClose":73.84,"latestTime":"09:29 EDT","volume":2911,"amount":214048.38003600002,"timestamp":1789133357153,"change":0.92,"changeRate":0.012459,"amplitude":0.04117},"postHourTrading":{"tag":"盘后","latestPrice":82,"preClose":81.41,"latestTime":"19:51 EDT","volume":2532,"amount":208418.93,"timestamp":1789170707443,"change":0.59,"changeRate":0.007247,"amplitude":0.017074},"volumeRatio":1.1097585784501116,"impliedVol":1.2558,"impliedVolPercentile":0.0833},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1097585784501116,"shares":320000,"dividePrice":0,"high":87.5,"amplitude":0.203819,"preClose":73.84,"low":72.45,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":81.41,"eps":0,"divideRate":0,"volume":259735,"delay":0,"ttmEps":0,"open":74.73,"prevYearClose":20.61,"prevWeekClose":84.15,"prevMonthClose":79.5,"prevQuarterClose":42.65,"fiveDayClose":88.29,"twentyDayClose":31.9518,"sixtyDayClose":28.6713},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191889577","title":"莫德納疫苗管線逐漸清晰，新藥前景牽動市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1191889577","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191889577?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 21:59","pubTimestamp":1785506345,"startTime":"0","endTime":"0","summary":"莫德纳公布了第二季度财报，营收达1.45亿美元，较去年同期微增约2%。然而，摩根大通的分析师指出，该公司的新冠疫苗业务高度集中于下半年。“我们预计市场不会过分关注本季度的具体营收数字，”分析师在研究报告中写道。至于管线进展，其一款诺如病毒疫苗在正在进行的关键临床试验中未达预期。与此同时，莫德纳预计其新型季节性流感疫苗有望在8月5日获得批准。“这意味着莫德纳将迎来第五个获批产品，但我们认为，仅凭此尚不足以推动公司踏上全新发展轨道，”分析师们评论道。莫德纳股价当日上涨1%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4548","BK4139","BK4501","MRNY","WDNA","BK4532","BK4534","GNOM","IDNA","MRNX","BK4551","BK4568","BK4588","MRNA","BK4585","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655638003","title":"更正-在等待美國就流感疫苗作出關鍵決定之際，Moderna的季度營收超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2655638003","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655638003?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:18","pubTimestamp":1785496718,"startTime":"0","endTime":"0","summary":"更新版 3-更正-在等待美国就流感疫苗作出关键决定之际，Moderna的季度营收超出预期诺如病毒候选疫苗面临临床试验挫折FDA将于8月5日前就流感疫苗作出决定Co下调年度研发支出预期第7段和第13段新增图表及高管评论，第10段和第15段新增分析师评论Mariam Sunny/Christy Santhosh路透7月31日-莫德纳公司周五公布的第二季度营收超出华尔街预期，这得益于疫苗合作款项及其新冠疫苗的国际销售收入，而投资者正等待美国监管机构对其流感疫苗的关键决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4T43X19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","PAWZ","LU0289739699.SGD","FHLC","LU1093756168.USD","IYH","BMED","LU0980610538.SGD","IE0002141913.USD","LU0070302665.USD","LU2357627491.SGD","LU1917777945.USD","MRNA","LU2112291526.USD","SG9999013999.USD","IXJ","LU1061106388.HKD","LU1699723380.USD","TRUH","VHT","GDOC","HRTS","MRK","MRNX","JDOC","LGHT","LU1162221912.USD","LU2361045086.USD","WDNA","LU2023250504.SGD","LU1066053197.SGD","RXL","BK4568","GNOM","LU2491050071.SGD","IDNA","LU0265550359.USD","LU0320765646.SGD","LU0823416689.USD","LU2125154935.USD","LU1035773651.USD","LU2433249047.HKD","LU0058720904.USD","XLV","IHE","SG9999014575.USD","FTXH","MRNY","LU1571399168.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191369993","title":"Moderna第二季度每股收益-1.97美元，優於IBES預期的-2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191369993","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191369993?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:16","pubTimestamp":1785496607,"startTime":"0","endTime":"0","summary":"Moderna公布的2026年第二季度财报显示，公司净亏损达8亿美元，折合每股收益为-1.97美元。这一数字，相较于市场通过IBES调查所预估的-2.08美元，表现略胜一筹。季度数据源自该公司于7月31日发布的官方财务报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNOM","BK4585","BK4533","IDNA","MRNX","LGHT","BK4532","MRNA","BK4551","BK4568","MRNY","WDNA","BK4548","BK4534","BK4588","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368109","title":"Moderna(MRNA.US)盤前跌5.7%二季度營收略低於預期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368109?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:04","pubTimestamp":1785495856,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LGHT","BK4532","BK4551","BK4568","GNOM","BK4533","BK4548","BK4534","BK4588","WDNA","IDNA","BK4501","MRNA","MRNY","MRNX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113092299","title":"Moderna宣佈：mRNA-1403 III期中期分析未達早期成功統計標準，正籌備新增隊列招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1113092299","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113092299?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:02","pubTimestamp":1785495775,"startTime":"0","endTime":"0","summary":"Moderna公司披露，其mRNA-1403候选药物在III期临床试验的中期分析中，并未达到预设的早期成功统计阈值。这一结果意味着，该药物未能展现出足以支撑其提前获批的显著疗效。尽管如此，公司并未止步于此。Moderna目前正紧锣密鼓地筹备，计划增设一个额外的受试者队列，以期进一步评估该药物的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IDNA","MRNX","BK4588","MRNY","BK4139","WDNA","BK4585","BK4568","BK4548","BK4534","BK4532","BK4551","GNOM","LGHT","MRNA","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145717315","title":"Moderna預期其第五款產品Mflusiva將於8月5日迎來PDUFA審批關鍵節點","url":"https://stock-news.laohu8.com/highlight/detail?id=1145717315","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145717315?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:02","pubTimestamp":1785495774,"startTime":"0","endTime":"0","summary":"Moderna公司近日释放积极信号，预计其第五款产品——针对Mflusiva的疗法，有望在今年8月5日的PDUFA日期获得监管批准。这一日期标志着FDA对该药物申请的最终审查期限，若顺利通关，将成为Moderna产品管线中的又一重要里程碑。目前，市场正密切关注这一审批进程，期待它为生物医药领域注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNOM","BK4585","BK4533","IDNA","MRNX","LGHT","BK4532","MRNA","BK4551","BK4568","MRNY","WDNA","BK4548","BK4534","BK4588","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800659","title":"今日關注要點——7月31日（星期五）","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800659","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655800659?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 02:30","pubTimestamp":1785436236,"startTime":"0","endTime":"0","summary":"今日关注要点——7月31日（星期五）《今日要闻》是一份通过电子邮件和PDF形式发布的刊物，内容涵盖当日主要新闻、事件、分析及其他专题报导。消费品制造商Church & Dwight则预计受需求疲软影响，第二季度营收将出现下滑。投资者将关注其新冠疫苗的销售情况，以及全年利润预期的任何调整。在加拿大经济方面，加拿大统计局计划发布5月份国内生产总值数据，预计将增长0.2%，此前为增长0.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL4T43W2IR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703095.HKD","BK4592","LU1066053197.SGD","LBO","DRLL","XOM","IXC","MRNX","LU1496350171.SGD","AAUM","WDNA","IE00B1XK9C88.USD","LU0971096721.USD","XLE","LU0690374615.EUR","LU0878866978.SGD","TEXU","WEEI","ARES","IE00BLSP4452.SGD","LGHT","GNOM","CL","MRNY","SG9999002224.SGD","GPZ","IDNA","FTXN","GXPE","BEN","OILT","IYE","BK4581","IGE","LU1074936037.SGD","PRVT","LU0266013472.USD","CVX","CHD","XOMZ","LU2430703251.USD","XOMX","FENY","DIG","VDE","XOMO","LU2237438978.USD","MRNA","TRUN","ERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655842772","title":"默克、惠康與一家全球衞生組織合作，共同研製埃博拉疫苗以用於臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2655842772","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655842772?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 13:03","pubTimestamp":1785387832,"startTime":"0","endTime":"0","summary":"默克与惠康基金会的合作将推动国际艾滋病疫苗倡议组织研发的单剂量疫苗的生产，世界卫生组织今年5月曾将其列为最具前景的候选疫苗。希勒曼公司将利用IAVI提供的起始原料，生产可用于早期临床试验的成品疫苗剂量。默克公司传染病与疫苗研发负责人塔里特·穆科帕迪亚在接受采访时表示，疫苗剂量有望在今年年底前准备就绪，用于临床试验。穆科帕迪亚表示，希勒曼实验室具备生产数万剂疫苗的能力，这应足以满足试验需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL4S43W0CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU1116320737.USD","LU2491050071.SGD","BK4548","BK4007","LU1035773651.USD","GDOC","IE00BJT1NW94.SGD","LU0266013472.USD","LU2106854487.HKD","LU1093756325.SGD","SG9999002232.USD","LU0868494708.USD","LU0965509283.SGD","LU2361044949.HKD","SG9999001176.USD","LU0320765489.SGD","BK4550","IE00B4R5TH58.HKD","LU0868494617.USD","LU2023250843.SGD","LU1061106388.HKD","TRUH","IE00BBT3K403.USD","LU0980610538.SGD","MRNX","LU0320765646.SGD","LU0070302665.USD","LU1571399168.USD","LU1917777945.USD","LU1162221912.USD","LU0477156953.USD","BK4533","BK4559","LU0985320562.USD","FHLC","LU0265550359.USD","LU0130102774.USD","LU1430594728.SGD","LU2125154778.USD","LU1023059063.AUD","SG9999014575.USD","LU2089984988.USD","LU1066051498.USD","SG9999015358.SGD","IDNA","LU0203347892.USD","LU2461242641.AUD","LU1941712264.USD","LU0648001328.SGD","LU0208291251.USD","LU1989771016.USD","LU1929549753.HKD","LU1069347547.HKD","LU0130517989.USD","LU1066053197.SGD","LU1585245621.USD","SG9999014542.SGD","BK4568","WDNA","LU0942090050.USD","LU1037948541.HKD","IYH","LU1989772923.USD","LU1934455863.HKD","HRTS","LU0211331839.USD","IE00BFTCPJ56.SGD","MRK","SG9999013999.USD","IE00B2B36J28.USD","PPH","LU0432979614.USD","LU2468319806.SGD","LU2023250504.SGD","PAWZ","BK4534","IXJ","LU2125909593.SGD","LU0058720904.USD","BK4139","LU2361045086.USD","IE00BLSP4452.SGD","LU2357627491.SGD","LU0965509101.SGD","BK4532","SGXZ57979304.SGD","LU0122379950.USD","LU2361044865.SGD","IE00BN8TJ469.HKD","XLV","LU2112291526.USD","IE00BLSP4239.USD","MRNA","LU0289739699.SGD","LU2125909247.SGD","JDOC","LU0203345920.USD","IE00BSNM7G36.USD","LU1934455277.USD","BK4588","FTXH","IE0002141913.USD","GNOM","LU1923622614.USD","LU0238689110.USD","BK4585","LU1941712348.USD","BK4501","LU1093756168.USD","RXL","IE00B1BXHZ80.USD","LU0234572021.USD","LU1066051811.HKD","SG9999001176.SGD","LU1699723380.USD","SG9999001440.SGD","SG9999015341.SGD","LU0124676726.USD","BK4551","MRNY","LU0689626769.HKD","LU0965509010.AUD","IE0009355771.USD","IE000M9KFDE8.USD","LU0965508806.USD","LU1057294990.SGD","LU0098860793.USD","LU1974910355.USD","LU1066051225.USD","LU1201861249.SGD","LU1291159041.SGD","LGHT","LU0006306889.USD","LU0265550946.USD","LU1116320901.HKD","VHT","BMED","LU2125154935.USD","LU1934455194.USD","SG9999014567.USD","IE00BJJMRZ35.SGD","SG9999002224.SGD","LU2491049909.HKD","LU2491050154.USD","LU0106261372.USD","LU1037948897.HKD","SG9999014559.SGD","BK4516","LU0859254822.USD","LU2433249047.HKD","LU2324357040.USD","LU0861579265.USD","IHE","LU1983299246.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654091684","title":"總部位於荷蘭阿姆斯特丹的全球生物製藥公司 ARGENX將以每股77美元的現金收購FORTE BIOSCIENCES。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654091684","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654091684?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 13:03","pubTimestamp":1785128639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","BBP","MRNY","UDN","IBBQ","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥  埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU0345777659.USD","LU1814569148.SGD","LU0708994859.HKD","LU1015430645.USD","BK0239","FHLC","LU0477156953.USD","IE00BKVL7J92.USD","LU0827474353.SGD","LU1153585028.USD","LU0964806797.USD","LU0047473722.EUR","LU1066051811.HKD","SG9999015358.SGD","BK4007","LU0053666078.USD","GDOC","LU0289739699.SGD","LU0238689110.USD","MRNX","SG9999001440.SGD","LU1674673428.USD","LU0792757196.USD","MRNY","SG9999001176.USD","LU0857590862.USD","LU1267930573.SGD","GILD","IE00BSNM7G36.USD","LU0234572021.USD","LU0203345920.USD","LU0345777147.USD","LU1116320737.USD","LU2324357040.USD","LU0965509010.AUD","IE0034235188.USD","LU1035773651.USD","LU0310799852.SGD","LU0648001328.SGD","LU0124676726.USD","LU0960981461.USD","LU1481599808.USD","BK4566","BK4583","LU2461242641.AUD","BK4533","MEDI","LU1934455194.USD","LU1674673691.USD","LU2539964713.USD","IE00BKPKM643.USD","BK4551","LU0887340254.USD","LU1267930813.SGD","LU0211331839.USD","SG9999015341.SGD","LU1291159041.SGD","LU1093756325.SGD","LU0823399737.USD","SG9999015952.SGD","03165","LU1003076772.USD","LU2279689827.SGD","LU1003077747.HKD","IBB","LU0757432116.USD","LU0689626769.HKD","IE0009355771.USD","LU0972486137.USD","LU1064927863.SGD","LU0208291251.USD","BIB","LU1019632923.USD","LU1119994496.HKD","LU1267930227.SGD","BK4548","RXL","LU0526926950.USD","BK4139","LU1917777945.USD","LU2108987350.USD","LU2360032135.SGD","LU1487256676.USD","LU2112291526.USD","IYH","LU1116320901.HKD","IE00BJT1NW94.SGD","LU1989771016.USD","LU2114397693.USD","LU1084165304.USD","BBH","LU1778281490.HKD","SG9999002232.USD","BK4198","OSUR","LU0109394709.USD","LU1496350502.SGD","JDOC","IXJ","LU1355424745.HKD","LU0661504455.SGD","LU0390134368.USD","IHE","LU1941712264.USD","TRUH","IE00B19Z3581.USD","LU0496365809.HKD","LU1430594728.SGD","LU0882574055.USD","LU2237438978.USD","IE00BN8TJ469.HKD","BK4534","LU0211328371.USD","GNOM","LU1571399168.USD","LU1496350171.SGD","LU2087621335.USD","LU0949170426.SGD","IE00BLSP4239.USD","LU1196032939.SGD","LU0784383803.USD","LU1983299246.USD","LU1267930490.SGD","LU2237443622.USD","LU2355687059.USD","LU0432979614.USD","LU0997586432.USD","LU1323610961.USD","LU1829250122.USD","LU2491049909.HKD","BK4588","LU0861579265.USD","LU1078025761.USD","LU2362541513.USD","LU2491050154.USD","LU1066051498.USD","LU2125154778.USD","LU2089984988.USD","LU0106261372.USD","LU0784384876.USD","LU1046234339.USD","PPH","LU0029864427.USD","LU0976567544.SGD","LU0823434740.USD","BK5011","LU2293690249.USD","LU0784385170.HKD","LU1880407132.USD","LU0557290698.USD","LU0889565916.HKD","REGN","LU0320765489.SGD","SG9999015945.SGD","LU2237443895.HKD","LU0114720955.EUR","LU0889565080.SGD","LU1989772923.USD","LU2361045086.USD","LU0171276677.USD","LU1162221912.USD","BK4585","LU1923622614.USD","LU1880407215.USD","LU0965509283.SGD","BK4578","LU0098860793.USD","LU1037948897.HKD","SG9999014559.SGD","LU0965509101.SGD","LU2237443978.SGD","LU0499090636.EUR","LU1481600234.SGD","LU1170363599.USD","WDNA","SG9999015986.USD","LU2023250504.SGD","LU0889566641.SGD","LU1585245621.USD","LU2491050071.SGD","LU1989772840.SGD","LU1104425308.USD","LU0545039389.USD","LU0077335932.USD","SG9999014575.USD","BK4516","LU0211326755.USD","LU1699723380.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU3187612489.SGD","SG9999013999.USD","LGHT","LU1066051225.USD","LU0949170772.SGD","TMED","LU0784385840.USD","LU0211326839.USD","IE00BZ1G4Q59.USD","LU2293690082.USD","IE00BFTCPJ56.SGD","LU0997586515.USD","LU0859254822.USD","BK4501","MRNA","IDNA","LU0070302665.USD","LU0738911758.USD","LU0234570918.USD","FTXH","LU2361044865.SGD","IE00B2B36J28.USD","LU0868494617.USD","LU1301847155.USD","LU0265550946.USD","LU1066053197.SGD","TBXU","LU1974910355.USD","LU0265550359.USD","LU0920840948.USD","LU1037948541.HKD","SG9999002224.SGD","LU2125909593.SGD","LU2237443549.SGD","LU0985320562.USD","LU1201861249.SGD","IE0002270589.USD","LU2089283258.USD","LU0171293334.USD","LU1051770623.HKD","SG9999014542.SGD","LU2361044949.HKD","LU0058720904.USD","LU0823434583.USD","LU0823416689.USD","HRTS","LU0963555726.SGD","LU1934455277.USD","LU0211327993.USD","IE00BBT3K403.USD","BK4568","LU0310800379.SGD","LU0868494708.USD","LU0203347892.USD","IE00B19Z3B42.SGD","LU0052756011.USD","LU0942090050.USD","IBBQ","IE00BLSP4452.SGD","LU2468319806.SGD","LU0130102774.USD","LU1941712348.USD","LU0128525929.USD","LU0128525689.USD","BK4550","LU1153584641.USD","XLV","LU0266013472.USD","IE00B1BXHZ80.USD","LU1863844749.USD","LU1934455863.HKD","LU2023250843.SGD","LU0158827948.USD","LU0575583348.USD","LU0320765992.SGD","LU2125154935.USD","LU2106854487.HKD","LU1057294990.SGD","LU2357627491.SGD","688317","LU2237443382.USD","LU0006306889.USD","LU0965508806.USD","LU0122379950.USD","LU2125909247.SGD","LU0640478417.SGD","BK4559","LU1273509221.SGD","AZN.UK","VHT","LU2433249047.HKD","LU0310800965.SGD","IE00B3T34201.USD","SG9999015978.USD","LU0320765646.SGD","SGXZ57979304.SGD","BK4532","LU2237443465.HKD","MRK","LU1929549753.HKD","LU0969580561.USD","LU0047473722.SGD","IE00B4R5TH58.HKD","LU1093756168.USD","IE000M9KFDE8.USD","LU0553294199.USD","LU2089284900.SGD","LU0130517989.USD","LU0011850046.USD","LU2091194634.USD","LU1023059063.AUD","LU2023251221.USD","BMED","SG9999014567.USD","IE0002141913.USD","LU2362541273.HKD","LU1863844665.USD","LU0957799991.USD","LU1019634622.SGD","LU2362540622.SGD","LU1261432733.SGD","LU0920783379.SGD","LU1061106388.HKD","LU1069347547.HKD","PAWZ","IE00B7SZLL34.SGD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752990","title":"安永：至2028年全球前25大醫藥企業存在千億美元增長缺口","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752990","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653752990?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:23","pubTimestamp":1784719424,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBBQ","MRNX","BBP","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653759874","title":"生物技術專家希望美國食品藥品監督管理局（FDA）的藥物評審基於科學，而非政治","url":"https://stock-news.laohu8.com/highlight/detail?id=2653759874","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653759874?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 18:01","pubTimestamp":1784714498,"startTime":"0","endTime":"0","summary":"生物技术专家希望美国食品药品监督管理局的药物评审基于科学，而非政治生物技术投资者希望监管具有可预测性马斯克的DOGE导致FDA裁减了3,000多个职位FDA现获准招聘2,200名员工特朗普政府正在考虑三位FDA局长候选人Deena Beasley路透7月22日-生物技术专家和行业高管认为，去年曾遭受裁员冲击的美国食品药品监督管理局计划招聘数千名员工并更新临床试验标准，这一举措令人鼓舞，但他们希望获得保证，确保政治因素不会干预该机构的药物审查流程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O0TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","NKTX","BK4585","GNOM","BK4551","BK4501","WDNA","MRNA","BK4568","BK4505","BK4588","BK4139","BK4532","LGHT","IDNA","BK4548","BK4534","MRNY","BK4533","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652212525","title":"莫德納稱，CureVac因就新冠疫苗專利提起訴訟而違反了協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2652212525","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652212525?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 23:37","pubTimestamp":1784561845,"startTime":"0","endTime":"0","summary":"莫德纳称，CureVac因就新冠疫苗专利提起诉讼而违反了协议Blake Brittain路透7月20日-莫德纳针对生物技术公司库尔瓦克就其畅销的新冠疫苗在特拉华州联邦法院提起的专利侵权诉讼进行了反诉，称该诉讼违反了双方之间的协议。莫德纳在周五提交的文件中称这两起诉讼均“毫无依据”。该证人此前曾在另一桩新冠疫苗专利案件中为莫德纳作证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL4T43M13V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU1057294990.SGD","LU1894683348.USD","BK4551","BK4501","BK4533","SG9999003800.SGD","LU1883839398.USD","LU0456855351.SGD","IE00BLSP4239.USD","LU1066051498.USD","MRNY","LU0170899867.USD","BK4535","LU0321505868.SGD","LU0306807586.USD","SGXZ57979304.SGD","LU0058720904.USD","BK4532","BK4550","IE00B3T34201.USD","WDNA","LU1066053197.SGD","SG9999001176.SGD","IE00BBT3K403.USD","LU0868494617.USD","BK4548","LU2596442595.SGD","OZEM","LU0122379950.USD","LGHT","LU0225284248.USD","LU0225771236.USD","SG9999001176.USD","SG9999002224.SGD","SG9999013999.USD","BK4534","MRNA","MRNX","BK4581","IE000M9KFDE8.USD","BK4592","LU0321505439.SGD","PFE","IDNA","SG9999011175.SGD","IE00B19Z3B42.SGD","BK4585","BNTX","LU0289739699.SGD","IE00BLSP4452.SGD","LU0234572021.USD","BK4139","LU0985481810.HKD","LU1023059063.AUD","BK4599","GNOM","IE0002270589.USD","LU1894683264.USD","BK4568","BK4588","IE00B19Z3581.USD","SG9999002232.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107107295","title":"Moderna宣佈首例患者接受針對實體瘤的研究性腫瘤靶向癌症抗原療法一期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1107107295","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107107295?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 19:42","pubTimestamp":1784202143,"startTime":"0","endTime":"0","summary":"Moderna, Inc.宣布，其研究性肿瘤靶向癌症抗原疗法在针对实体瘤的一期临床试验中，已为首例患者完成给药。该试验旨在评估该疗法的安全性与初步疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","MRNY","BK4551","LGHT","MRNX","BK4532","BK4533","BK4139","BK4568","BK4548","GNOM","IDNA","BK4585","MRNA","BK4534","BK4588","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651462903","title":"賽諾菲就新冠疫苗技術起訴輝瑞和莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2651462903","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651462903?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 23:57","pubTimestamp":1784131036,"startTime":"0","endTime":"0","summary":"赛诺菲就新冠疫苗技术起诉辉瑞和莫德纳Blake Brittain路透7月15日-赛诺菲SASY.PA已起诉辉瑞PFE.N和莫德纳MRNA.O，指控这两家公司的新冠疫苗侵犯了这家法国制药公司的多项专利。赛诺菲  于周二在新泽西州联邦法院提起的两起诉讼  指控称，这些畅销疫苗侵犯了该公司在信使核糖核酸技术方面的专利权。周三，辉瑞和莫德纳的发言人未立即回应就赛诺菲新诉讼置评的请求。莫德纳于2022年以专利侵权为由起诉辉瑞 ，该案目前仍在审理中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL4S43H1KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","IE00B3T34201.USD","LU1023059063.AUD","BK4585","SG9999001176.SGD","LU1894683348.USD","IE0002270589.USD","BK4581","BK4550","IE00B19Z3581.USD","LU0306806265.USD","GNOM","BK4551","SG9999002232.USD","SNY","BK4501","OZEM","LU0289739699.SGD","LU1883839398.USD","MRNA","BK4568","SG9999013999.USD","WDNA","BK4588","BK4532","BK4139","LU0456855351.SGD","SGXZ57979304.SGD","LU0306807586.USD","LU1066051498.USD","LU2596442595.SGD","SG9999002224.SGD","LGHT","LU1066053197.SGD","LU0985481810.HKD","IDNA","BK4548","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0321505868.SGD","LU0868494617.USD","LU0170899867.USD","LU1057294990.SGD","SG9999001176.USD","LU0225771236.USD","SG9999011175.SGD","LU0058720904.USD","BK4007","IE00BLSP4452.SGD","PFE","LU1894683264.USD","BK4534","IE00BFXG1179.USD","LU0321505439.SGD","MRNY","IE00BLSP4239.USD","LU0234572021.USD","IE000M9KFDE8.USD","BK4592","LU0122379950.USD","BK4599","SG9999003800.SGD","BK4533","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651774435","title":"免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市 擬募資1億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651774435","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651774435?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 11:17","pubTimestamp":1784085422,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。该公司计划在纳斯达克上市，股票代码为“ATTO”。　　据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260715/32307966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["MRNY","MRNX","IPOS","BBP","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435511","title":"免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市 擬募資1億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435511","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435511?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。自通过IPO融资2.2亿美元以来，Alamar股价已上涨近60%。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。Attovia的核心候选药物ATTO-1310针对白细胞介素-31，目前已完成针对健康志愿者以及患有慢性瘙痒症和特应性皮炎患者的Ⅰ期临床试验给药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","MRNX","BBP","MRNY","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435505","title":"免疫疾病生物製藥公司Attovia(ATTO.US)申請在美上市 擬募資1億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435505?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BBP","MRNX","MRNY","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651160208","title":"傑富瑞：將Moderna(MRNA.US)目標價從53美元上調至60美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651160208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651160208?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 11:55","pubTimestamp":1783914940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IDNA","UUP","BK4532","BK4568","BK4588","UDN","LGHT","BK4551","BK4534","BK4533","WDNA","BK4501","BK4139","GNOM","MRNX","MRNA","MRNY","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651161841","title":"重温-美國股市：標普500指數接近紀錄高位，投資者目光轉向財報季","url":"https://stock-news.laohu8.com/highlight/detail?id=2651161841","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651161841?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 07:30","pubTimestamp":1783899000,"startTime":"0","endTime":"0","summary":"本周美国和伊朗之间的袭击事件令市场再次担心，能源价格高企可能推升通胀，并迫使美联储加息。美国大型银行下周将拉开第二季度财报季序幕。得益于企业盈利预估上调，标普500指数目前的预期市盈率约为20倍，低于5月下旬的21倍，尽管该指标股指已处于纪录高位附近。标普500指数上涨0.42%，收于7,575.39点，较6月2日创下的纪录收盘高位仍低0.45%。本周，标普500指数上涨1.2%，纳指攀升1.7%，道指下跌0.5%。标普500指数涨跌股家数比为2.1:1。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260712:nL6S43C14Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XDAT","FBL","LU1035775433.USD","FBY","VOX","GNOM","LU2746668461.USD","FCOM","JETS","LTL","LU0784383803.USD","OGIG","SKHYV","LU0265550359.USD","LU1791710582.SGD","METU","LU0348723411.USD","LU1235294995.USD","FBYY","LU0889565833.HKD","NULC","XLC","LU0949170772.SGD","LU0310799852.SGD","METD","DAL","MRNA","BK4548","LU2458330169.SGD","LU2756315664.SGD","META","LU2133065610.SGD","LU0724617625.USD","RSPC","LU0738911758.USD","LGHT","METV","MRNX","LU2462591350.SGD","SKHY","LU0823421416.USD","METW","WDNA","BK4139","SOCL","LU2242650005.HKD","MRNY","LU0786609619.USD","LU2487616109.SGD","IDNA","LU2322448791.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}